文献速递先天性心脏病外科

体重<2.5kg症状性法洛四联症新生儿管理策略比较

Comparison of management strategies for neonates with symptomatic tetralogy of Fallot and weight <2.5 kg.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-02-03

本研究回顾性比较了体重<2.5kg的症状性法洛四联症新生儿接受分期修复(SR)与一期修复(PR)的结果。SR组调整后手术并发症和新生儿疾病负担总体较低,但累积次要结局负担多倾向于PR组。

要点

  • 体重<2.5kg症状性法洛四联症新生儿总体死亡率和再干预负担高,与初始策略无关。
  • 分期修复与一期修复的调整后死亡风险相似(HR 0.59,95%CI 0.26-1.36)。
  • SR组调整后手术并发症和新生儿疾病负担较低,但累积次要结局多倾向PR组。

核心结论

  • 在体重<2.5kg的症状性法洛四联症新生儿中,分期修复与一期修复的死亡率和再干预负担均高且与治疗策略无关。

研究设计与样本

  • 回顾性队列研究,纳入2005至2017年先天性心脏研究协作组中体重<2.5kg的症状性法洛四联症新生儿,比较分期修复(SR,n=76)与一期修复(PR,n=44),采用倾向评分调整,以PR为参照组。

主要发现

  • SR组调整后手术并发症和新生儿疾病负担总体较低,累积次要结局负担多倾向于PR组。

临床怎么用

  • 对于体重<2.5kg的症状性法洛四联症新生儿,选择分期修复或一期修复需权衡各自潜在优势,两种策略死亡风险相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare management strategies for neonates <2.5 kg with tetralogy of Fallot and symptomatic cyanosis who either undergo staged repair (SR) (initial palliation followed by later complete repair) or primary repair (PR). METHODS: Consecutive neonates with tetralogy of Fallot and symptomatic cyanosis weighing <2.5 kg at initial intervention and between 2005 and 2017 were retrospectively reviewed from the Congenital Cardiac Research Collaborative. Primary outcome was mortality and secondary outcomes included component (eg, initial palliation, complete repair, or primary repair) and cumulative (SR: initial palliation followed by later complete repair) hospital and intensive care unit lengths of stay, durations of ventilation, inotrope use, cardiopulmonary bypass time, procedural complications, and reintervention. Outcomes were compared with propensity score adjustments with PR as the reference group. RESULTS: The cohort included 76 SR (initial palliation: 53 surgical and 23 transcatheter) and 44 PR patients. The observed risk of overall mortality was similar between SR and PR groups (15.8% vs 18.2%: P = .735). The adjusted hazard of mortality remained similar between groups overall (hazard ratio, 0.59; 95% confidence interval, 0.26-1.36; P = .214), as well as during short-term (<4 months: hazard ratio, 0.37; 95% confidence interval, 0.13-1.09; P = .071) and midterm (>4 months: hazard ratio, 1.32; 95% confidence interval, 0.30-5.79; P = .717) follow-up. Reintervention in the first 18 months was common in both groups (53.2% vs 48.4%; hazard ratio, 1.69; 95% confidence interval, 0.96-2.28; P = .072). Adjusted procedural complications and neonatal morbidity burden were overall lower in the SR group. Cumulative secondary outcome burdens largely favored the PR group. CONCLUSIONS: In this study comparing SR and PR treatment strategies for neonates with tetralogy of Fallot and symptomatic cyanosis and weight <2.5 kg, mortality and reintervention burden was high and independent of treatment strategy. Other potential advantages were observed with each approach.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Qureshi AM, Caldarone CA, Romano JC, et al. Comparison of management strategies for neonates with symptomatic tetralogy of Fallot and weight <2.5 kg. J Thorac Cardiovasc Surg. 2021. PMID: 33726912. doi:10.1016/j.jtcvs.2021.01.100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。